Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
13.06
+0.49 (3.90%)
At close: Nov 6, 2026, 4:00 PM EST
13.24
+0.18 (1.38%)
Pre-market: Nov 9, 2026, 7:01 AM EST
Generate Biomedicines Revenue
Generate Biomedicines had revenue of $6.31M in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $26.48M. In the year 2025, Generate Biomedicines had annual revenue of $31.89M with 55.89% growth. That makes Generate Biomedicines the 32,175th largest company in the world by revenue and 4,235th in the United States.
Revenue (ttm)
$26.48M
Revenue Growth
+55.89%
P/S Ratio
63.30
Revenue / Employee
$84,881
Employees
312
Market Cap
1.68B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 31.89M | 11.43M | 55.89% |
| Dec 31, 2024 | 20.46M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
GENB News
- 18 days ago - Generate Biomedicines to Participate in November Investor Conferences - GlobeNewsWire
- 23 days ago - Generate Biomedicines management to meet with Cantor - TheFly
- 26 days ago - Generate Biomedicines, Zealand Pharma enter protein therapeutics pact - TheFly
- 26 days ago - Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases - GlobeNewsWire
- 26 days ago - Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases - GlobeNewsWire
- 5 weeks ago - Generate Biomedicines, Roswell Park dose first patient in GB-5267 trial - TheFly
- 5 weeks ago - Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored' CAR T Therapy for Ovarian Cancer - GlobeNewsWire
- 6 weeks ago - Generate Biomedicines Transcript: Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum - Transcripts